31st Jan 2011 12:19
For immediate release | 31 January 2011 |
Oxford BioMedica Plc
Notification of Major Interest in Shares
TR-1: Notifications of Major Interests in Shares | |||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Oxford BioMedica Plc | ||
2. Reason for notification (yes/no) | |||
An acquisition or disposal of voting rights | Yes | ||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||
An event changing the breakdown of voting rights | |||
Other (please specify):______________ | |||
3. Full name of person(s) subject to notification obligation: |
Cubana Investments Limited
| ||
4. Full name of shareholder(s) (if different from 3): | |||
5. Date of transaction (and date on which the threshold is crossed or reached if different): |
28 January 2011 | ||
6. Date on which issuer notified: |
31 January 2011 | ||
7. Threshold(s) that is/are crossed or reached: |
13% | ||
8: Notified Details | |||||||||||
A: Voting rights attached to shares
| |||||||||||
Class/type of shares If possible use ISIN code
GB0006648157
| Situation previous to the triggering transaction | Resulting situation after the triggering transaction
| |||||||||
Number of shares
54,824,711 | Number of voting rights
54,814,711 | Number of shares
125,300,000 | Number of voting rights | Percentage of voting rights | |||||||
Direct
125,300,000 |
Indirect
|
Direct
13.26% |
Indirect | ||||||||
B: Financial Instruments
| |||||||||||
Resulting situation after the triggering transaction
| |||||||||||
Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights | |||||||
| |||||||||||
Total (A+B)
| |||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||
125,300,000 | 13.26% | ||||||||||
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: | |
Proxy Voting:
| |
10. Name of proxy holder:
| |
11. Number of voting rights proxy holder will cease to hold:
| |
12. Date on which proxy holder will cease to hold voting rights:
| |
13. Additional information:
| |
14 Contact name:
| Andrew Wood |
15. Contact telephone number:
| 01865 783000 |
Related Shares:
Oxford Biomedica